FIP releases report on common ailment schemes across nations

Pharmacists played a vital role in managing the increasing demand for primary healthcare.

The International Pharmaceutical Federation (FIP) launched a report on pharmacy-led common ailment schemes.

The data was collected from 24 countries, including case studies from nine countries.

It highlighted the growing demand for care models for ageing populations and the increase in chronic non-communicable diseases.

Pharmacists had been managing the stress, including prescribing authority and provision of medicinal treatments.

Paul Sinclair AM, Global President of FIP, said, "I believe this report is both a foundation and a catalyst — a foundation on which FIP and our member organizations could base initial strategies and a catalyst to drive us to seek even more diverse and comprehensive insights in the future.

"By equipping pharmacists with the tools and knowledge they needed, we strived to ensure that patients had access to timely, informed, and personalized care."

The common ailment schemes offered improved access to care, enhanced patient quality of life, and cost-effective alternatives while reducing GP workloads.

However, operational challenges persisted due to inconsistencies in service requirements and stakeholder engagement, including variations in professional standards, formularies, geographical coverage, and remuneration pathways.

Public funding was the primary source of remuneration for these schemes, with additional training mandated in two-thirds of countries.

Community pharmacists worldwide offered early interventions for common conditions, capitalizing on their accessible locations, and benefiting patients.

The report talked about the existing models and encouraged FIP member organizations to promote pharmacy-based services.

FIP led in enhancing primary healthcare excellence and accessibility, endorsing the expansion of common ailment schemes to bolster healthcare access and system strength.